Dr Peggy Ann O'cain, MD | |
340 Stateline Rd W, Southaven, MS 38671-1610 | |
(662) 510-5387 | |
Not Available |
Full Name | Dr Peggy Ann O'cain |
---|---|
Gender | Female |
Speciality | Family Medicine - Addiction Medicine |
Location | 340 Stateline Rd W, Southaven, Mississippi |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356392567 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0203X | Pediatrics - Pediatric Critical Care Medicine | 40884 (Tennessee) | Secondary |
207QA0401X | Family Medicine - Addiction Medicine | 29923 (Mississippi) | Primary |
Entity Name | Pediatric Emergency Specialists, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760482434 PECOS PAC ID: 7810800679 Enrollment ID: O20031107000315 |
News Archive
The National Institutes of Health has awarded a four-year, $1.4 million grant to Cedars-Sinai's Department of Neurology to study an unexpected recent discovery: After ischemic stroke - the type caused by a clogged artery but with no bleeding into the brain - a normal protein that plays a positive role in blood clotting escapes intact arteries and damages healthy brain cells.
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) to acute myeloid leukemia. The finding could improve prognostication for patients with MDS and better inform therapeutic decision making.
In an effort to educate and engage Hispanic parents in youth drug prevention, the nation's Drug Czar, John P. Walters, First Lady Columba Bush, and Director of the Florida Office of Drug Control Policy, Jim McDonough, today unveiled a new national Spanish-language advertising campaign.
Squamous cell carcinomas are aggressive malignancies arising from squamous epithelium of various organs, such as esophagus, head and neck, lung and skin. Previous studies demonstrated that two master transcription factors, TP63 and SOX2, effect genomic activation in SCCs.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Peggy Ann O'cain, MD 66 N. Pauline, Suite 206, Memphis, TN 38105-5105 Ph: (901) 448-2869 | Dr Peggy Ann O'cain, MD 340 Stateline Rd W, Southaven, MS 38671-1610 Ph: (662) 510-5387 |
News Archive
The National Institutes of Health has awarded a four-year, $1.4 million grant to Cedars-Sinai's Department of Neurology to study an unexpected recent discovery: After ischemic stroke - the type caused by a clogged artery but with no bleeding into the brain - a normal protein that plays a positive role in blood clotting escapes intact arteries and damages healthy brain cells.
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) to acute myeloid leukemia. The finding could improve prognostication for patients with MDS and better inform therapeutic decision making.
In an effort to educate and engage Hispanic parents in youth drug prevention, the nation's Drug Czar, John P. Walters, First Lady Columba Bush, and Director of the Florida Office of Drug Control Policy, Jim McDonough, today unveiled a new national Spanish-language advertising campaign.
Squamous cell carcinomas are aggressive malignancies arising from squamous epithelium of various organs, such as esophagus, head and neck, lung and skin. Previous studies demonstrated that two master transcription factors, TP63 and SOX2, effect genomic activation in SCCs.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that data relating to the company's oncolytic virus therapy for cancer was featured in three separate abstracts during the American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago, Illinois.
› Verified 5 days ago
Saif M Tahsin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-772-2980 Fax: 662-772-2960 | |
Dr. Beth A Choby, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7736 Airways Blvd, Southaven, MS 38671 Phone: 662-772-3700 Fax: 662-772-3719 | |
John Carl Biery Jr., D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7736 Airways Blvd, Southaven, MS 38671 Phone: 662-772-3700 Fax: 662-772-3719 | |
Dr. Gary Dwain Carr, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6858 Swinnea Rd Bldg 7, Southaven, MS 38671 Phone: 662-510-8400 Fax: 662-510-8500 | |
Walter Earl Carnahan, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7900 Airways Blvd, Bldg A Suite 6, Southaven, MS 38671 Phone: 662-536-4646 Fax: 662-536-4443 | |
Jennifer B Warren, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3495 Cobblestone Blvd S, Southaven, MS 38672 Phone: 662-892-2885 Fax: 662-890-1551 | |
Dr. Nabeel Syed Ali, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-772-2980 Fax: 662-772-2960 |